Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Moelis Reiterates Buy Rating for Alexium and Price Target of $1.20

RPT

http://media.marketwire.com/attachments/201411/82012_alexium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1258533&ProfileId=051205&sourceType=1

PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 05/10/16 --


Highlights

  • Moelis report highlights Alexium growth in coatings and polymer market.
  • Alexium on target for revenue goals.

Alexium International Group Limited ("Alexium," "the Company") (Alexium) (ASX: AJX) (OTCQX: AXXIY) The Company has announced that Moelis Securities Pty Ltd., issued a report on 10 May on Alexium, updating estimates to reflect recent Company developments including the announcement of success and further expansion into the coatings and polymer market.

"The Moelis rating of 'buy' with a 12 month price target of $1.20 is recognition of Alexium's significant presence in the market," said Nicholas Clark, Alexium CEO. "We remain on track for our mid-year and year-end goals."

The Moelis report can be accessed by visiting www.alexiuminternational.com and selecting "Investors" and then "Investor Research."

About Moelis

Moelis and Company is a global independent investment bank that provides financial advisory services to corporations, governments and financial sponsors. The firm advisors on strategic decisions such as mergers and acquisitions, recapitalizations and restructurings and other corporate finance matters. Moelis was founded in 2007 and is headquartered in New York, with 17 offices in North and South America, Europe, the Middle East, Asia and Australia. It has 650 employees including 450 investment bankers.

About Alexium
Alexium International Group Limited (ASX: AJX, AX:AJX OTC QX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatments are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks. For additional information about Alexium, please visit www.alexiuminternational.com.

U. S. Corporate Offices:

1100 New York Avenue, Suite 710W
Washington DC 20001

148 Milestone Way, Suite B,
Greenville, SC 29615



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today